Delivery Order SPE2DR25D3501-SPE2DR26FL8UT
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for PADCEV 20 MG vials valued at $3,695.90 by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with no set-aside designation applied. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.80 to AmerisourceBergen Drug Corp for the supply of PADCEV 30 mg vials. This contract is a firm fixed-price delivery order with no set-aside designation, issued competitively on July 21, 2025, and scheduled for completion by August 11, 2025. The products will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $14,783.60 to AmerisourceBergen Drug Corp for Padcev 20 mg vials, with a firm fixed price and an ultimate completion date of December 1, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract is a firm fixed-price delivery order with a ceiling value of $39,998.88 and is set to be completed by September 5, 2024. Amerisourcebergen is providing these critical pharmaceutical products to support military treatment facilities and other federal healthcare providers. This delivery order is part...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for Padcev 20 mg vials on November 4, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order is non-set-aside and competitively awarded, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a $27.7K delivery order by the Defense Logistics Agency's Medical Supply Chain to supply 30 mg vials of Padcev, a specialized oncology medication. The contract, executed on September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price, non-set-aside competitive award. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a ceiling value of $11,087.60 and a completion date of February 27, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The order is for PADCEV 20 MG VIALS, a specialty pharmaceutical product, with a completion date of March 14, 2024 and a potential value of $13,318.56. This delivery order is issued under an indefinite delivery contract (IDC) held by...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PADCEV 30 MG vials. The order has a potential value of $116,823.84 and a completion date of June 1, 2023. Amerisourcebergen Drug Corp is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical facilities and programs. This delivery order...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $9,999.72, is for the delivery of the pharmaceutical product PADCEV 30 MG VIALS. The contract has a firm fixed price pricing type and a completion date of May 21, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL8UTDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of PADCEV (ado-trastuzumab vedotin) 20 mg vials, with a ceiling value of $11,684.76. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and was competitively awarded through an open procurement process. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle that encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 11/17/25 |